Marcelo Amar
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 25
- Surgery top 1%
- Cholesterol and Lipid Metabolism 33
- Lipoproteins and Cardiovascular Health 22
- Cancer Research top 2%
- Biochemistry top 1%
- Lipid metabolism and biosynthesis 8
- Oncology top 2%
- Drug Transport and Resistance Mechanisms 16
-
- Peroxisome Proliferator-Activated Receptors 14
-
- Lipid metabolism and disorders 13
-
- Atherosclerosis and Cardiovascular Diseases 6
- Co-authors
- Alan T. RemaleySilvia Santamarina-FojoRobert D. ShamburekBoris VaismanH. Bryan BrewerGilles LambertLita A. FreemanJamila Fruchart‐Najib
- Journals
- Journal of Lipid Research (8 papers)Journal of Biological Chemistry (7 papers)Journal of Clinical Investigation (6 papers)
- Partner nations
- United StatesFranceAustralia
In The Last Decade
Marcelo Amar
85 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Endocrinology, Diabetes and Metabolism 1.4k
- Surgery 2.8k
- Cancer Research 829
- Biochemistry 376
- Oncology 1.0k
Countries citing papers authored by Marcelo Amar
This map shows the geographic impact of Marcelo Amar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcelo Amar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcelo Amar more than expected).
Fields of papers citing papers by Marcelo Amar
This network shows the impact of papers produced by Marcelo Amar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcelo Amar. The network helps show where Marcelo Amar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marcelo Amar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2021 | 11 | |
| 3 | 2020 | 5 | |
| 4 | 2020 | 17 | |
| 5 | A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemiabreakdown → | 2020 | 312 |
| 6 | 2018 | 11 | |
| 7 | 2017 | 4 | |
| 8 | 2017 | 150 | |
| 9 | 2015 | 73 | |
| 10 | 2014 | 48 | |
| 11 | 2010 | 69 | |
| 12 | 2009 | 74 | |
| 13 | 2009 | 140 | |
| 14 | 2008 | 77 | |
| 15 | 2006 | 51 | |
| 16 | Abstract 256: The ApoA-I Peptide Mimetic 5A Protects Against Atherosclerosis in ApoE Deficient Mice | 2006 | 1 |
| 17 | 2005 | 91 | |
| 18 | 2003 | 37 | |
| 19 | 2001 | 190 | |
| 20 | 1998 | 201 |
About Marcelo Amar
Marcelo Amar is a scholar working on Endocrinology, Diabetes and Metabolism, Biochemistry, Surgery, Cardiology and Cardiovascular Medicine and Oncology, having authored 85 papers that have together received 5.2k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (33 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (25 papers), Lipoproteins and Cardiovascular Health (22 papers), Drug Transport and Resistance Mechanisms (16 papers), Peroxisome Proliferator-Activated Receptors (14 papers), Lipid metabolism and disorders (13 papers), Lipid metabolism and biosynthesis (8 papers) and Atherosclerosis and Cardiovascular Diseases (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.4k citations), Surgery (2.8k citations), Cancer Research (829 citations), Biochemistry (376 citations) and Oncology (1.0k citations). Marcelo Amar has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Alan T. Remaley, Silvia Santamarina-Fojo, Robert D. Shamburek, Boris Vaisman, H. Bryan Brewer, Gilles Lambert, Lita A. Freeman, Jamila Fruchart‐Najib, Beverly Paigen and Changting Haudenschild. Their work appears in journals such as Journal of Lipid Research, Journal of Biological Chemistry, Journal of Clinical Investigation, The Journal of Immunology and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.